Evidence map›Paper›PMID 37266024›Full record

ArticleFrontiers in microbiology2023

Molecular epidemiology and clinical characteristics of the type VI secretion system in

Peilin Liu, Awen Yang, Bin Tang, Zhiqian Wang, Zijuan Jian, Yanjun Liu, Jiahui Wang, Baiyun Zhong, Qun Yan, Wenen Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Multidrug-resistant hypervirulentFuture microbiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Animal models ofFrontiers in microbiology · 2024
    Review
  15. Article
  16. Performance of next-generation sequencing for diagnosis of blood infections byFrontiers in cellular and infection microbiology · 2023
    Article
  17. Review
  18. HypervirulentInfection and drug resistance · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Peilin LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Awen YangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Bin TangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhiqian WangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zijuan JianDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yanjun LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiahui WangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Baiyun ZhongDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Qun YanDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wenen LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The type VI system (T6SS) has the potential to be a new virulence factor for hypervirulent Patients and methods: A total of 169 non-duplicate Results: The positive detection rate for T6SS was 36.1%. The rates of hvKp, seven virulence genes, K1 capsular serotype, and ST23 in T6SS-positive strains were all higher than those in T6SS-negative strains ( Conclusion:

Indexed as

abscesshypervirulenthypervirulent Klebsiella pneumoniae (hvKP)type VI system (T6SS)virulence

Identifiers

PMID37266024
PMCPMC10230222
OpenAlexW4377041415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.